{
    "code": "56029542",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56029542",
    "time": "2020-02-26 08:06:09",
    "許可證字號": "衛部醫器輸字第029542號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD6663",
    "有效日期": "111\/04\/14",
    "發證日期": "106\/04\/14",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602954207",
    "中文品名": "邦迪斯歐普羅補體4分析套組",
    "英文品名": "The Binding Site Optilite C4 Kit",
    "效能": "本產品搭配邦迪斯歐普羅系統使用，於體外定量在血清、肝素鋰鹽和EDTA血漿中的補體4。",
    "醫器規格": "NK025.OPT，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5240補體成份免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6231118886  太暘生物科技股份有限公司",
    "申請商地址": "新北市汐止區福德三路369號12樓",
    "主製造廠": {
        "製造廠名稱": "MGB0438200  THE BINDING SITE GROUP LTD",
        "製造廠廠址": "8 CALTHORPE ROAD, EDGBASTON, BIRMINGHAM, B15 1QT, UNITED KINGDOM",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED KINGDOM",
        "製程": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560295420001-106-05-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029542&Seq=001&Type=9"
        },
        {
            "title": "560295420002-106-05-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029542&Seq=001&Type=8"
        }
    ]
}